Permanent Contraceptive Declares War On Women: Forced Hysterectomies

Posted by: Steven Ahle Posted date: November 13, 2013 In: News, Videos

 2601  7 Google +1  2  3

Ad Info

The Essure permanent contraceptive for women was supposed to a simple way for women to prevent future pregnancies.  This device is slipped into the fallopian tubes.  Tissue grows around it and prevents the sperm from passing through to the egg.  But we are just learning about major problems they can cause.

Nikki Morris from Haines City , is a 26-year-old, mother of three, who had the procedure.  Afterwards, she was in great pain.  As it turned out, she was allergic to nickel, the material making up part of the Essure device.  Unfortunately, the device cannot just be taken back out.  It requires a hysterectomy.  So far, hundreds of women have had to have this procedure done, yet the procedure is still readily available.
Hundreds of women and doctors have filed reports of the adverse effects of the devices which are made by Concuptus Inc, which is owned by Bayer.
Erin Brockovich, the woman who fought against PG&E in the groundwater contamination case back in 1991, played by Julia Roberts, has taken up this cause as she explains:

“There’s something wrong with the device, in my opinion.  It’s a form of permanent birth control, and women’s organs are being perforated … it’s ridiculous that at any level we try to defend this. If 30 women did suffer harm for unknown reason, we’d investigate. We have thousands injured. I don’t think it’s safe.”

Brockovich notes that the Essure is a class three device, which protects the manufacturer from lawsuits.
Bayer has issued a statement after the FDA report that said no action was warranted.
At Bayer, we care about patients and take the safety of our products very seriously.  We are saddened to hear of any serious health condition affecting a patient using one of our products, irrespective of the cause.  Essure was approved by the FDA in 2002, and has a well-documented benefit-risk profile, with over 400 peer-reviewed publications and abstracts supporting Essure’s safety, efficacy and cost-effectiveness.  Approximately 750,000 women worldwide rely upon the Essure procedure for permanent birth control.  A recent practice bulletin issued by the American College of Obstetricians and Gynecologists (ACOG) has recognized that hysteroscopic tubal occlusion for sterilization has high efficacy and low procedure-related risk, cost, and resource requirements.
No form of birth control is without risk or should be considered appropriate for every woman.  It is important that women discuss the risks and benefits of any birth control option with their physicians.
Thank you again for allowing us to provide our commentary.